Kailong Li

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Advanced Non Small Cell Lung Cancer

Top Venues

Nature metabolism

Signal transduction and targeted therapy

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yao Yao, Fei Ye, Kailong Li, Peng Xu, Wenjie Tan, Quansheng Feng, Shuquan Rao
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19. Signal transduction and targeted therapy 6 (1) (2021)
Kailong Li, Yuannyu Zhang, Xin Liu, Zhimin Gu, Hui Cao, Kathryn E Dickerson, Mingyi Chen, Weina Chen, Zhen Shao, Min Ni, Jian Xu
Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies. Cancer discovery 10 (5) (2020)
Jiyeon Kim, Hyun Min Lee, Feng Cai, Bookyung Ko, Chendong Yang, Elizabeth L Lieu, Nefertiti Muhammad, Shawn Rhyne, Kailong Li, Mohamed Haloul, Wen Gu Lai, Brandon Faubert, Akash K Kaushik, Ling Cai, Sahba Kasiri, Ummay Marriam, Kien Nham, Luc Girard, Hui Wang, Xiankai Sun, James Kim, John D Minna, Keziban Unsal-Kacmaz, Ralph J DeBerardinis
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nature metabolism 2 (12) (2020)